BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 12434411)

  • 1. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
    Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
    J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
    Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
    J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial cell cyclooxygenase-2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas.
    Chapple KS; Scott N; Guillou PJ; Coletta PL; Hull MA
    J Pathol; 2002 Dec; 198(4):435-41. PubMed ID: 12434412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas.
    Pisano C; Ottaiano A; Tatangelo F; Di Bonito M; Falanga M; Iaffaioli VR; Botti G; Pignata S; Acquaviva AM
    Anticancer Res; 2005; 25(3B):2065-8. PubMed ID: 16158946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas.
    Chapple KS; Cartwright EJ; Hawcroft G; Tisbury A; Bonifer C; Scott N; Windsor AC; Guillou PJ; Markham AF; Coletta PL; Hull MA
    Am J Pathol; 2000 Feb; 156(2):545-53. PubMed ID: 10666384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.
    Hull MA; Booth JK; Tisbury A; Scott N; Bonifer C; Markham AF; Coletta PL
    Br J Cancer; 1999 Mar; 79(9-10):1399-405. PubMed ID: 10188882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
    Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Cyclooxygenase expression and colorectal adenoma characteristics.
    Einspahr JG; Krouse RS; Yochim JM; Danenberg PV; Danenberg KD; Bhattacharyya AK; Martínez ME; Alberts DS
    Cancer Res; 2003 Jul; 63(14):3891-3. PubMed ID: 12873979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 in sporadic colorectal polyps: immunohistochemical study and its importance in the early stages of colorectal tumorigenesis.
    Tatsu K; Hayashi S; Shimada I; Matsui K
    Pathol Res Pract; 2005; 201(6):427-33. PubMed ID: 16136748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S; Bamba H; Kato A
    Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics.
    McLean MH; Murray GI; Fyfe N; Hold GL; Mowat NA; El-Omar EM
    Histopathology; 2008 Jun; 52(7):806-15. PubMed ID: 18462368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
    Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
    Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.
    Tanaka S; Tatsuguchi A; Futagami S; Gudis K; Wada K; Seo T; Mitsui K; Yonezawa M; Nagata K; Fujimori S; Tsukui T; Kishida T; Sakamoto C
    Gut; 2006 Jan; 55(1):54-61. PubMed ID: 16085694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression in human gastric tubular adenomas and carcinomas; correlation with intratumoral microvessel density and apoptotic index.
    Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
    Anticancer Res; 2004; 24(3a):1439-44. PubMed ID: 15274307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas.
    Sheehan KM; O'Connell F; O'Grady A; Conroy RM; Leader MB; Byrne MF; Murray FE; Kay EW
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):619-25. PubMed ID: 15167166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.